Genetic polymorphisms in human Cyp2a6 gene and interindividual differences in nicotine metabolism

被引:0
|
作者
Nakajima, M [1 ]
Yoshida, R [1 ]
Nishimura, K [1 ]
Kwon, JT [1 ]
Yokoi, T [1 ]
机构
[1] Kanazawa Univ, Fac Pharmaceut Sci, Div Drug Metab, Kanazawa, Ishikawa 920, Japan
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We determined the phenotyping of in vivo nicotine metabolism and the genotyping of the CYP2A6 gene in 92 Japanese and 209 Koreans. Among them, 3 Japanese and 4 Korean subjects who were absolutely deficient in cotinine formation were genotyped as CYP2A6*4 (whole deletion)/CYP2A6*4. The other poor metabolizers whose nicotine metabolism was impaired were genotyped as CYP2A6*4/CYP2A6*7 (I471T) or CYP2A6*4/CYP2A6*10 (I471T, R485L). The cotinine/nicotine ratio as an index of nicotine metabolism could be put in the order of subjects genotyped as CYP2A6*1A/CYP2A6*1A > CYP2A6*1A/ CYP2A6*9 (T-48G) > CYP2A6*9/CYP2A6*9. Thus, nicotine metabolism was impaired by CYP2A6*4, CYP2A6*7, and CYP2A6*10 alleles and was decreased by CYP2A6*9 allele.
引用
收藏
页码:257 / 260
页数:4
相关论文
共 50 条
  • [21] Relationship between CYP2A6 Genetic Polymorphism, as a Marker of Nicotine Metabolism, and Ulcerative Colitis
    Altarescu, Gheona
    Rachmilewitz, Daniel
    Zevin, Shoshana
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2011, 13 (02): : 87 - 90
  • [22] CYP2A6 genetic polymorphisms and liver microsomal coumarin and nicotine oxidation activities in Japanese and Caucasians
    Kiyoshi Inoue
    Hiroshi Yamazaki
    Tsutomu Shimada
    Archives of Toxicology, 2000, 73 : 532 - 539
  • [23] Polymorphisms of nicotine metabolism genes CYP2A6 and CYP2B6 and their effect on smoking addiction in chinese han population
    Wang, Hongjuan
    Fu, Yaning
    Chen, Huan
    Liu, Tong
    Han, Shulei
    Hou, Hongwei
    Hu, Qingyuan
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2020, 127 : 35 - 35
  • [24] CYP2A6 genetic polymorphisms and liver microsomal coumarin and nicotine oxidation activities in Japanese and Caucasians
    Inoue, K
    Yamazaki, H
    Shimada, T
    ARCHIVES OF TOXICOLOGY, 2000, 73 (10-11) : 532 - 539
  • [25] Effects of whole deletion of CYP2A6 on nicotine metabolism in humans
    Zhang, X
    Ameno, K
    Ameno, S
    Kinoshita, H
    Kubota, T
    Kumihashi, M
    Mostofa, J
    Iwahashi, K
    Ijiri, I
    DRUG AND CHEMICAL TOXICOLOGY, 2002, 25 (02) : 203 - 213
  • [26] Grapefruit juice inhibits CYP2A6 and nicotine metabolism.
    Hukkanen, J
    Benowitz, NL
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P75 - P75
  • [27] Is nicotine-craving linked to genetic variants of CYP2A6?
    Riexinger, A
    Collins, S
    Gaertner, L
    Farger, G
    Batra, A
    NICOTINE & TOBACCO RESEARCH, 2005, 7 (04) : 653 - 653
  • [28] CYP2A6 Polymorphisms May Strengthen Individualized Treatment for Nicotine Dependence
    Akrodou, Yawo Mawuli
    SCIENTIFICA, 2015, 2015 : 1 - 7
  • [29] Hepatic CYP2A6 levels and nicotine metabolism: impact of genetic, physiological, environmental, and epigenetic factors
    Al Koudsi, Nael
    Hoffmann, Ewa B.
    Assadzadeh, Abbas
    Tyndale, Rachel F.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (03) : 239 - 251
  • [30] Hepatic CYP2A6 levels and nicotine metabolism: impact of genetic, physiological, environmental, and epigenetic factors
    Nael Al Koudsi
    Ewa B. Hoffmann
    Abbas Assadzadeh
    Rachel F. Tyndale
    European Journal of Clinical Pharmacology, 2010, 66 : 239 - 251